No way this stock will fly like last year. There simply are no incentives and with the MCO, production will be affected

Thanks, I will throw and run very far.

Gone with the wind. Final data or not, the drop is real.

Look at the candle. Gap up? Let's see where it finishes. Macd is weakening. Not surprised if it drops back to 0.70

Looks like it is game over - or 15 sen coming again?

LKL is not only involved in beddings for hospitals. With KKM's estimate of 5,000 cases a day next month, quarantine at home may not be viable - and I think they are also looking at hotels and other premises for help, including private hospitals. If my guess is right, private hospitals that treat covid patients will refurbish their beds once the pandemic is over because of the stigma. but let's watch and see what happens. By the way, what about LKL's glove venture to China. Any news from there yet?

@
paulthesotong Final " data" n testing coming out end of this mth or early Feb..." Suprising" " Home Run"
20/01/2021 7:22 AM

What data? That it is ready for Phase 3 or FDA approves? If so, you are not looking at 80sen but maybe $8, but heck, just wait

Flash in the pan - already people start selling down. hard times, looking for fast buck. be careful.

Good beginnings

https://www.thestar.com.my/business/business-news/2021/01/18/quick-take-kanger-gains-3-on-diversification-into-construction

Monitor Generex stock on the US exchange under OTC. markets. That will be your signal

Sinopharm was approved by China on dec 31. Malaysia will do phase trials on Jan 21

GNBT hit a high of USD45 yesterday before retracing. Something is developing fast at Generex Biotech - it must be its li-peptide based vaccine. That it has attracted substantial funds is no surprise and by association, Bintai Kinden now has something - apart from the distribution of the Korean cold-trans box for vaccines - to bank on. Let's watch the take-up today. The charts look good - MA 5/20 looks promising

Pfizer vaccine needs cold trans. One other company ready to tap into this is AHealth. Now that BK is also on the bandwagon, you can bet the playing rules has just gotten interesting. Vaccine considered as well, BK must first break 0.79 resistance to head for greater days reflected by its fundamentals. Next resistance if 0.79 is broken will be 0.96

GNBT is is the rise - meaning their research into li-peptide based vaccines are drawing interest. This is the stock that one should monitor. It is today 0.40 - a far cry from its 0.19 price some months back. What is interesting is if you look at its technicals, it is on the climb - especially markedly yesterday. Anticipate some announcement of sorts to come soon. And if it does, then you will see some interesting fireworks in BK by sheer association

This is just a measure to prevent a general election - a political emergency so that politicians are tied down.

PM said phase 3 volunteer testing of the China vaccine will begin in nine days time. It will involved 3,000. Now the question to as is if Kanger is still the distributor for this China vaccine (Singopharm's Verocell). If it is, then you may draw your own conclusions.

The speech:

"37. Kajian klinikal yang pertama dilakukan di Malaysia ini dijangka akan melibatkan seramai 3,000 sukarelawan dan Malaysia bakal menjadi negara pertama di luar negara China untuk kajian calon vaksin inactivated COVID-19 vaccine buatan Institute of Medical Biology Chinese Academy of Medical Sciences, China (IMBCAMS) ini. Kesemua keperluan regulatori termasuk kelulusan etika dari Medical Review & Ethics Committee (MREC) dan akhir sekali, Clinical Trial Import License (CTIL) dari NPRA telah diperolehi pada 8 Januari 2021."

Heard PM announced about import licences for China vaccines approved by NPRA. Can anyone confirm?

Big news coming over the weekend?

buy as much as you want, but the vaccine aint coming.

Breakdown is more likely.

Looks like it is dropping till 11 sen

Drops as she comes.

Not only beds - gloves as well. Look at the gloves counters fly.

When prices drop, look at volume. If volume is small, that's your buying opportunity. So wait for it to go lower even. Then pick up at what u feel is lowest, based on technical predictions.

Another of strict lockdowns means more off-line usage, and cloud computing will be emphasised on more than ever. If you think enterprise harddisk demand will taper down, think again. Look at the US and UK, dont even count Europe just yet.

Here, go figure:

https://www.straitstimes.com/asia/se-asia/malaysias-new-covid-19-cases-hit-high-of-2593-hospital-beds-fill-up

Look at the volume of people getting tested daily at private hospitals. Park City Medical Centre had to close its admission for testing yesterday because of high volume of people who want to get swabbed. Usually private medical centres do not turn away business. This will help you gauge potential of hospital stocks.

Correct, but it could also mean it does not intend to distribute reasons being too crowded with higher profile companies.

Maybe Kanger is even not distributing the vaccine, which is why they have not come up with any statement despite so many positive news on this China vaccine. If kanger is distributing, why isnt it make any press statement on the progress of its venture?

If this can break 0.78 over next few days, you can hope for the retracement back to 0.83 and chart new high above 90sen for the year, setting a benchmark for next year's growth.

No need to worry if you bought in at 30sen previously. It's only a matter of when to sell, if to sell.

Dont tell me they are announcing something material about the vaccine? Or maybe bamboo contracts with China?

What gloves is AT making when until now nothing to show?

*Both contracts are very much dependent on AT, as we do not know whether LKL has any other distributorship agreement with other glove suppliers. LKL does not manufacture gloves. The whole thing look much more convincing should they ink an agreement with the big brothers (TopG, Supermx, Hartalega, Kossan).*

If hospital beds are in shortage, and gloves contracts have been inked, shouldnt the price reflect higher value?

I think this quarrel about vaccine or bamboo should stop. It litters this forums with unnecessary reading material. If only you people is as hardworking to seek fundamental reports or technical studies of this counter, and share it, then it will be somewhat more productive and useful.

@
Shootup If brazil approves coronavac on wed, sure kanger will fly again

Kanger to distribute Verocell. Nothing to do with Coronavac

Too many retailers. Only when retailers are reduced, you can hope this con-ter will rise again

Just hope for 7sen. 20sen is far fetched.

Bintai still has nothing to show except papers of MoUs. So sentiments now will reflect its fundamentals

Maybe Cubetech getting some kind of deal

The coming days will see who is telling the truth - Kanger should come clean with current ventures, not just vaccine but others as well. Right now, investor relations is zero

maybe insider news already that is why price and volume go up

It will not touch 0.20 again for at least another year. wasting time getting your blood pressure up will get you nowhere.

Today close 0.07 - if not, 0.06, and still not, 0.045

@slpless Of cos there will be no middle man because you will buy directly from the licensed distributors in the region.The ChinaPress news is fake news. If it is half true, the western medias would have make it sound like end of the world!

You have facts that say otherwise?

@ Miguel_Felix


See? Even Sinopharm is smart enough to do damage control. They made sure the resumption of trials is relayed to the public. Although Kanger purportedly will distribute this Verocell from Sinopharm, it is not saying anything since the last announcement by the KKM. If only their investor relations is doing its job, I am very sure market confidence will rise in tandem.
17/12/2020 10:34 AM

This is your answer why Kanger is being trashed.

https://www.youtube.com/watch?fbclid=IwAR21IMz52M1cy_pcmDHzG-LoVVSLM1C45y1tQVrpHve_5k29r_F97-e-9ZM&v=8O_SMPjhbi8&feature=youtu.be

@
CAF-POW If the Yellow page collaboration with TM is sucessful, I think this will be extra revenue stream for this counter.

I think it is already signed - they share 50:50 profits. APpasia is using its expertise to create e-marketing platform form TM in yellow pages which has a huge database of untapped potential Coupled with Appasia's cloud-centric applications, I think you can roughly guess where it will be appropriately priced.

bamboo or vaccine, it is back to 16-16.5 play - that sums up what the sentiments on the ground are. Buy today, sell today.

@NPRA1985

you have any stories about Malaysian distribution channels? Zuellig has been appointed - maybe see who else and how many outlets or which hospitals they target. Then you can narrow down the odds